Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity

doi:10.1084/jem.177.6.1723

This Article

	Full Text (PDF, 2417K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by North, R. J.
	Articles by Izzo, A. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by North, R. J.
	Articles by Izzo, A. A.


Social Bookmarking

	What's this?

ARTICLES

Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity

RJ North and AA Izzo
Trudeau Institute, Inc., Saranac Lake, New York 12983.

The kinetics of growth of two virulent strains of mycobacteria (M. tuberculosis Erdman and M. tuberculosis H37Rv) and two attenuated strains (M. tuberculosis H37Ra and M. bovis Bacillus Calmette-Guerin [BCG]) were studied in the lungs, livers, spleens, and kidneys of severe combined immunodeficient (SCID) mice and of their coisogenic CB- 17 immunocompetent counterparts. It was found, in keeping with the findings of earlier investigators (Pierce, C. H., R. J. Dubos, and W. B. Schaefer. 1953. J. Exp. Med. 97:189.), that in immunocompetent mice, virulent organisms grew progressively only in the lungs, whereas the growth of attenuated organisms was controlled in all organs. In SCID mice, in contrast, virulent mycobacteria grew rapidly and progressively in all organs, as did BCG, although at a slower rate. However, H37Ra failed to grow progressively in any organs of SCID mice, unless the mice were treated with hydrocortisone. In fact, hydrocortisone treatment enabled virulent, as well as attenuated, organisms to grow strikingly more rapidly in all organs of SCID mice and in all organs of CB-17 mice. A histological study showed that in SCID mice, multiplication of mycobacteria in the liver occurs in the cytoplasm of macrophages in granulomas and presumably in macrophages in other organs. It is suggested, therefore, that the macrophages of SCID mice possess a glucocorticoid-sensitive mycobacterial mechanism that prevents virulent and avirulent mycobacteria from expressing their true minimal doubling times. In the absence of this mechanism in the lungs of hydrocortisone-treated SCID mice, the doubling times of Erdman, H37Rv, BCG, and H37Ra were 17.7, 17.4, 44.6, and 98.6 h, respectively. The possible importance of a rapid multiplication rate for mycobacterial virulence is discussed.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Sad, S., Dudani, R., Gurnani, K., Russell, M., van Faassen, H., Finlay, B., Krishnan, L. (2008). Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells. J. Immunol. 180: 5853-5861 [Abstract] [Full Text]
Russell, M. S., Iskandar, M., Mykytczuk, O. L., Nash, J. H. E., Krishnan, L., Sad, S. (2007). A Reduced Antigen Load In Vivo, Rather Than Weak Inflammation, Causes a Substantial Delay in CD8+ T Cell Priming against Mycobacterium bovis (Bacillus Calmette-Guerin). J. Immunol. 179: 211-220 [Abstract] [Full Text]
Theus, S. A., Cave, M. D., Eisenach, K., Walrath, J., Lee, H., Mackay, W., Whalen, C., Silver, R. F. (2006). Differences in the Growth of Paired Ugandan Isolates of Mycobacterium tuberculosis within Human Mononuclear Phagocytes Correlate with Epidemiological Evidence of Strain Virulence. Infect. Immun. 74: 6865-6876 [Abstract] [Full Text]
Kashino, S. S., Ovendale, P., Izzo, A., Campos-Neto, A. (2006). Unique model of dormant infection for tuberculosis vaccine development.. CVI 13: 1014-1021 [Abstract] [Full Text]
Raghunand, T. R., Bishai, W. R. (2006). Mycobacterium smegmatis whmD and its homologue Mycobacterium tuberculosis whiB2 are functionally equivalent.. Microbiology 152: 2735-2747 [Abstract] [Full Text]
Luu, R. A., Gurnani, K., Dudani, R., Kammara, R., van Faassen, H., Sirard, J.-C., Krishnan, L., Sad, S. (2006). Delayed Expansion and Contraction of CD8+ T Cell Response during Infection with Virulent Salmonella typhimurium. J. Immunol. 177: 1516-1525 [Abstract] [Full Text]
Park, J. S., Tamayo, M. H., Gonzalez-Juarrero, M., Orme, I. M., Ordway, D. J. (2006). Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J. Leukoc. Biol. 79: 80-86 [Abstract] [Full Text]
Rindi, L., Fattorini, L., Bonanni, D., Iona, E., Freer, G., Tan, D., Deho, G., Orefici, G., Garzelli, C. (2002). Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice. Microbiology 148: 3873-3880 [Abstract] [Full Text]
Dullaghan, E. M., Malloff, C. A., Li, A. H., Lam, W. L., Stokes, R. W. (2002). Two-dimensional bacterial genome display: a method for the genomic analysis of mycobacteria. Microbiology 148: 3111-3117 [Abstract] [Full Text]
Cheon, S.-H., Kampmann, B., Hise, A. G., Phillips, M., Song, H.-Y., Landen, K., Li, Q., Larkin, R., Ellner, J. J., Silver, R. F., Hoft, D. F., Wallis, R. S. (2002). Bactericidal Activity in Whole Blood as a Potential Surrogate Marker of Immunity after Vaccination against Tuberculosis. CVI 9: 901-907 [Abstract] [Full Text]
Gordhan, B. G., Smith, D. A., Alderton, H., McAdam, R. A., Bancroft, G. J., Mizrahi, V. (2002). Construction and Phenotypic Characterization of an Auxotrophic Mutant of Mycobacterium tuberculosis Defective in L-Arginine Biosynthesis. Infect. Immun. 70: 3080-3084 [Abstract] [Full Text]
Scanga, C. A., Mohan, V. P., Tanaka, K., Alland, D., Flynn, J. L., Chan, J. (2001). The Inducible Nitric Oxide Synthase Locus Confers Protection against Aerogenic Challenge of Both Clinical and Laboratory Strains of Mycobacterium tuberculosis in Mice. Infect. Immun. 69: 7711-7717 [Abstract] [Full Text]
Zahrt, T. C., Deretic, V. (2001). Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc. Natl. Acad. Sci. USA 98: 12706-12711 [Abstract] [Full Text]
Mills, J. W., Ryan, L., LaCourse, R., North, R. J. (2001). Extensive Mycobacterium bovis BCG Infection of Liver Parenchymal Cells in Immunocompromised Mice. Infect. Immun. 69: 3175-3180 [Abstract] [Full Text]
Smith, D. A., Parish, T., Stoker, N. G., Bancroft, G. J. (2001). Characterization of Auxotrophic Mutants of Mycobacterium tuberculosis and Their Potential as Vaccine Candidates. Infect. Immun. 69: 1142-1150 [Abstract] [Full Text]
Wigginton, J. E., Kirschner, D. (2001). A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis. J. Immunol. 166: 1951-1967 [Abstract] [Full Text]
Fulton, S. A., Martin, T. D., Redline, R. W., Henry Boom, W. (2000). Pulmonary Immune Responses during Primary Mycobacterium bovis- Calmette-Guerin Bacillus Infection in C57Bl/6 Mice. Am. J. Respir. Cell Mol. Bio. 22: 333-343 [Abstract] [Full Text]
Malik, Z. A., Denning, G. M., Kusner, D. J. (2000). Inhibition of Ca2+ Signaling by Mycobacterium tuberculosis Is Associated with Reduced Phagosome-Lysosome Fusion and Increased Survival within Human Macrophages. JEM 191: 287-302 [Abstract] [Full Text]
Scanga, C. A., Mohan, V. P., Joseph, H., Yu, K., Chan, J., Flynn, J. L. (1999). Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model. Infect. Immun. 67: 4531-4538 [Abstract] [Full Text]
Manca, C., Tsenova, L., Barry, C. E. III, Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., Kaplan, G. (1999). Mycobacterium tuberculosis CDC1551 Induces a More Vigorous Host Response In Vivo and In Vitro, But Is Not More Virulent Than Other Clinical Isolates. J. Immunol. 162: 6740-6746 [Abstract] [Full Text]
Power, C. A., Wei, G., Bretscher, P. A. (1998). Mycobacterial Dose Defines the Th1/Th2 Nature of the Immune Response Independently of Whether Immunization Is Administered by the Intravenous, Subcutaneous, or Intradermal Route. Infect. Immun. 66: 5743-5750 [Abstract] [Full Text]
Lyadova, I., Yeremeev, V., Majorov, K., Nikonenko, B., Khaidukov, S., Kondratieva, T., Kobets, N., Apt, A. (1998). An Ex Vivo Study of T Lymphocytes Recovered from the Lungs of I/St Mice Infected with and Susceptible to Mycobacterium tuberculosis. Infect. Immun. 66: 4981-4988 [Abstract] [Full Text]
Valway, S. E., Sanchez, M. P. C., Shinnick, T. F., Orme, I., Agerton, T., Hoy, D., Jones, J. S., Westmoreland, H., Onorato, I. M. (1998). An Outbreak Involving Extensive Transmission of a Virulent Strain of Mycobacterium tuberculosis. NEJM 338: 633-639 [Abstract] [Full Text]
Silver, R. F., Li, Q., Ellner, J. J. (1998). Expression of Virulence of Mycobacterium tuberculosis within Human Monocytes: Virulence Correlates with Intracellular Growth and Induction of Tumor Necrosis Factor Alpha but Not with Evasion of Lymphocyte-Dependent Monocyte Effector Functions. Infect. Immun. 66: 1190-1199 [Abstract] [Full Text]
Zhang, M., Gong, J., Lin, Y., Barnes, P. F. (1998). Growth of Virulent and Avirulent Mycobacterium tuberculosis Strains in Human Macrophages. Infect. Immun. 66: 794-799 [Abstract] [Full Text]
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., Nathan, C. F. (1997). Identification of nitric oxide synthase as a protective locus against�tuberculosis. Proc. Natl. Acad. Sci. USA 94: 5243-5248 [Abstract] [Full Text]